Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Laurianne Grignou"'
Autor:
Guillaume Manson, Alexandre Thibault Jacques Maria, Florence Poizeau, François-Xavier Danlos, Marie Kostine, Solenn Brosseau, Sandrine Aspeslagh, Pauline Du Rusquec, Maxime Roger, Maud Pallix-Guyot, Marc Ruivard, Léa Dousset, Laurianne Grignou, Dimitri Psimaras, Johan Pluvy, Gilles Quéré, Franck Grados, Fanny Duval, Frederic Bourdain, Gwenola Maigne, Julie Perrin, Benoit Godbert, Beatris Irina Taifas, Alexandra Forestier, Anne-Laure Voisin, Patricia Martin-Romano, Capucine Baldini, Aurélien Marabelle, Christophe Massard, Jérôme Honnorat, Olivier Lambotte, Jean-Marie Michot
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-12 (2019)
Abstract Background Paraneoplastic syndromes (PNS) are autoimmune disorders specifically associated with cancer. There are few data on anti-PD-1 or anti-PD-L1 immunotherapy in patients with a PNS. Our objective was to describe the outcome for patient
Externí odkaz:
https://doaj.org/article/ca72d3ba97984c078f0aec5f8467a55e
Autor:
Alberto, Vogrig, Marine, Fouret, Bastien, Joubert, Géraldine, Picard, Véronique, Rogemond, Anne-Laurie, Pinto, Sergio, Muñiz-Castrillo, Maxime, Roger, Judith, Raimbourg, Charles, Dayen, Laurianne, Grignou, Maud, Pallix-Guyot, Julien, Lannoy, François, Ducray, Virginie, Desestret, Dimitri, Psimaras, Jérôme, Honnorat
Publikováno v:
Neurology® Neuroimmunology & Neuroinflammation
Objective To report the induction of anti–Ma2 antibody–associated paraneoplastic neurologic syndrome (Ma2-PNS) in 6 patients after treatment with immune checkpoint inhibitors (ICIs). We also analyzed (1) patient clinical features compared with a
Autor:
Julie Perrin, Florence Poizeau, Johan Pluvy, Alexandra Forestier, Franck Grados, Capucine Baldini, Maud Pallix-Guyot, Dimitri Psimaras, Solenn Brosseau, Laurianne Grignou, Jean-Marie Michot, Alexandre Thibault Jacques Maria, Guillaume Manson, Aurélien Marabelle, Olivier Lambotte, Benoit Godbert, Jérôme Honnorat, Fanny Duval, Maxime Roger, Pauline Du Rusquec, Frederic Bourdain, G. Maigné, Léa Dousset, Marie Kostine, Christophe Massard, Anne-Laure Voisin, Gilles Quere, Sandrine Aspeslagh, François-Xavier Danlos, Marc Ruivard, Beatris Irina Taifas, Patricia Martin-Romano
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer, 2019, 7 (1), ⟨10.1186/s40425-019-0821-8⟩
Journal for Immunotherapy of Cancer, BMJ Publishing Group 2019, 7 (1), ⟨10.1186/s40425-019-0821-8⟩
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-12 (2019)
Journal for Immunotherapy of Cancer, 2019, 7 (1), ⟨10.1186/s40425-019-0821-8⟩
Journal for Immunotherapy of Cancer, BMJ Publishing Group 2019, 7 (1), ⟨10.1186/s40425-019-0821-8⟩
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-12 (2019)
International audience; BACKGROUND:Paraneoplastic syndromes (PNS) are autoimmune disorders specifically associated with cancer. There are few data on anti-PD-1 or anti-PD-L1 immunotherapy in patients with a PNS. Our objective was to describe the outc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::065c8f6f198dd5a55e3fed28f218cc77
https://doi.org/10.1186/s40425-019-0821-8
https://doi.org/10.1186/s40425-019-0821-8